One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells….
HLA-DRB1 molecule can be a potential target in treating acute myeloid leukemia
